Focused ultrasound-mediated brain genome editing

Area of Science:

• Neuroscience
• Biotechnology
• Medical Imaging

Background:

• Gene editing in the brain faces significant hurdles due to the blood-brain barrier (BBB), limiting therapeutic delivery.
• Current methods often require invasive local injections, restricting treatment applicability and safety.

Purpose of the Study:

• To develop a novel, non-invasive method for delivering gene editing machinery across the BBB.
• To evaluate the safety and efficacy of focused ultrasound (FUS) in facilitating brain gene editing.

Main Methods:

• Utilized focused ultrasound (FUS) to temporarily permeabilize the blood-brain barrier (BBB).
• Administered CRISPR/Cas9 gene editing components intravenously following FUS treatment.
• Assessed the transport and efficacy of the gene editing machinery within the brain.

Main Results:

• Demonstrated successful and transient opening of the BBB using FUS.
• Confirmed the delivery of intravenously administered CRISPR/Cas9 to the brain.
• Established FUS as a safe and effective approach for brain gene editing delivery.

Conclusions:

• Focused ultrasound (FUS) offers a promising non-invasive strategy for overcoming BBB limitations in gene editing.
• This technique enhances the potential for treating neurological disorders through targeted brain gene editing.